WeedMD Inc. and CannTx Life Sciences Sign Definitive Acquisition Agreement and Confirm Corporate Name as Entourage Health Corp.
14 juil. 2021 07h15 HE
|
WeedMD Rx Inc.
On closing, merged company to combine innovative medical business, low-cost cultivation, specialized craft cannabis, micropropagation, and solventless extraction capabilitiesTop-selling, award-winning...
WeedMD Inc. Announces Intent to Change Corporate Name to Entourage Health Corp.
05 juil. 2021 08h15 HE
|
WeedMD Rx Inc.
Company reports results of Annual General & Special Meeting of Shareholders held on June 30, 2021 which includes overwhelming shareholder approval for corporate rebrandCompany confirms the...
WeedMD Reports First Quarter 2021 Financial Results with 102% Record Increase in Sequential Net Revenue Growth
29 juin 2021 07h15 HE
|
WeedMD Rx Inc.
Total revenue (before excise duties) of $12.9 million in Q1 2021, represents over 7% favourability over the $12.0 million Q1 2021 guidance previously providedNet revenue of $10.3 million in Q1 2021,...
WeedMD Expands its Color Cannabis Brand into the Province of New Brunswick
28 juin 2021 14h16 HE
|
WeedMD Rx Inc.
TORONTO, June 28, 2021 (GLOBE NEWSWIRE) -- WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally licensed producer and distributor of medical-grade cannabis, is...
WeedMD Sells Fully Licensed Bowmanville Operating Assets
15 juin 2021 08h00 HE
|
WeedMD Rx Inc.
Closes share-sale transaction with Final Bell Canada Inc. following Starseed Medicinal’s full production and product fulfillment move to Company’s consolidated London-area facilities Concludes site...
WeedMD Inc. Provides Bi-Weekly Status Report Regarding Management Cease Trade Order and Update Regarding Interim Financial Statements
14 juin 2021 17h30 HE
|
WeedMD Rx Inc.
/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ TORONTO, June 14, 2021 (GLOBE NEWSWIRE) -- WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or...
WeedMD and Privately Owned CannTx Life Sciences Sign Letter of Intent to Create a Cannabis Cultivation and Consumer-Centric Product Portfolio
31 mai 2021 08h05 HE
|
WeedMD Rx Inc.
Strategic acquisition of innovative, specialized cannabis operator will fold in micro-propagation technology, a craft portfolio, and solventless extraction capabilities Complementary operations and...
WeedMD Reports Fiscal Year 2020 Financial Results and First Quarter 2021 Preliminary Gross Revenue of $12 Million
31 mai 2021 07h24 HE
|
WeedMD Rx Inc.
Net revenue increased 41% YOY to $29.4 million for the full year ended December 31, 2020Kilograms harvested in 2020 grew 88% over prior year to 33,751 with more Grade A flowerWeighted average cost per...
WeedMD to Host Fiscal Year End 2020 Conference Call on May 31st
21 mai 2021 08h18 HE
|
WeedMD Rx Inc.
Company financials to be filed after market on May 28, 2021 and operational outlook to be provided during call, including first quarter 2021 record milestones achieved TORONTO, May 21, 2021 (GLOBE...
WeedMD Launches New Product Collaboration with CannTx Life Sciences for Release of Limited Edition Cultivars to Starseed Medicinal
17 mai 2021 08h09 HE
|
WeedMD Rx Inc.
TORONTO, May 17, 2021 (GLOBE NEWSWIRE) -- WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally licensed producer and distributor of medical-grade cannabis, is...